Last updated: February 3, 2025
Sponsor: University Health Network, Toronto
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Blood group A2 donor to blood group O recipient lung transplant surgery
Clinical Study ID
NCT05581745
21-5005
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
first lung transplant
blood group O recipient
low pre-operative anti-A antibody titers
consent to study participation
Exclusion
Exclusion Criteria:
re-transplant
multiorgan transplant
positive virtual crossmatch at time of transplant
Study Design
Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Blood group A2 donor to blood group O recipient lung transplant surgery
Phase:
Study Start date:
July 14, 2022
Estimated Completion Date:
December 31, 2033
Connect with a study center
Toronto General Hospital, University Health Network
Toronto, Ontario M5G 2C4
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.